WestminsterResearch

A randomised placebo-controlled trial of oral hydrocortisone for treating tobacco withdrawal symptoms

Ussher, Michael and Aveyard, Paul and Reid, Fiona and West, Robert and Evans, Philip D. and Clow, Angela and Hucklebridge, Frank and Fuller, Julie and Ibison, Judith and Steptoe, Andrew (2011) A randomised placebo-controlled trial of oral hydrocortisone for treating tobacco withdrawal symptoms. Psychopharmacology, 216 (1). pp. 43-51. ISSN 0033-3158

Full text not available from this repository.

Official URL: http://dx.doi.org/10.1007/s00213-011-2191-x

Abstract

Rationale - Many smokers experience a decline in cortisol to sub-normal levels during the first days of smoking cessation. A greater decline in cortisol is associated with more intense cigarette withdrawal symptoms, urge to smoke and relapse to smoking. Findings from an uncontrolled study suggest that glucocorticoids could ameliorate cigarette withdrawal. Objectives - We investigated whether taking oral hydrocortisone would reduce withdrawal symptoms and the desire to smoke on the first day of temporary smoking abstinence compared with placebo. Methods - Using a double-blind within-subject randomised crossover design, 48 smokers took a single dose of 40 mg hydrocortisone, 20 mg hydrocortisone or placebo following overnight smoking abstinence. Abstinence was maintained through the afternoon, and withdrawal symptoms and the desire to smoke were rated across the morning. Salivary cortisol was assessed in the afternoon prior to abstinence (baseline) and while abstinent after each treatment. Results - There was a significant dose–response relation between dose of hydrocortisone and reduction in depression and anxiety ratings while abstinent, but there were no other statistically significant associations with dose. Overall, the decline in cortisol following smoking cessation (placebo only) was not significant. Cortisol level on the afternoon of smoking abstinence was not significantly associated with symptom ratings. Conclusions - Supplements of hydrocortisone do not reduce the desire to smoke but may ameliorate withdrawal-related depression and anxiety, although the clinical benefit is slight.

Item Type:Article
Research Community:University of Westminster > Social Sciences, Humanities and Languages, School of
ID Code:9813
Deposited On:22 Sep 2011 10:27
Last Modified:22 Sep 2011 10:27

Repository Staff Only: item control page